Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Skanes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Immunogenetics|January 1, 1985
C4B3 allotype with a novel Ch phenotypeV M Skanes, B Larsen, C M Giles
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4B D Reilly, R P Levine, V M Skanes
Molecular Immunology|July 1, 1994
Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formationB D Reilly, V M Skanes, R P Levine
Rheumatology (Oxford, England)|July 26, 2000
Major histocompatibility complex phenotypes influence serum testosterone concentrationB Larsen, C A King, M Simms, et al.
Complement and Inflammation|January 1, 1991
Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4BB D Reilly, P Levine, J Rothbard, et al.
Molecular Immunology|September 1, 1988
The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulinsN Kishore, D Shah, V M Skanes, et al.
Complement (Basel, Switzerland)|January 1, 1988
C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1L Paul, V M Skanes, J Mayden, et al.
Autoimmunity|January 1, 1988
Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye diseaseM Frecker, G Mercer, V M Skanes, et al.
Arthritis and Rheumatism|September 1, 1987
Deletion of C4A genes in patients with systemic lupus erythematosusM E Kemp, J P Atkinson, V M Skanes, et al.
Molecular Biology & Medicine|April 1, 1986
Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditisV M Skanes, J Barnard, N Farid, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Immunogenetics|January 1, 1985
C4B3 allotype with a novel Ch phenotypeV M Skanes, B Larsen, C M Giles
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4B D Reilly, R P Levine, V M Skanes
Molecular Immunology|July 1, 1994
Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formationB D Reilly, V M Skanes, R P Levine
Rheumatology (Oxford, England)|July 26, 2000
Major histocompatibility complex phenotypes influence serum testosterone concentrationB Larsen, C A King, M Simms, et al.
Complement and Inflammation|January 1, 1991
Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4BB D Reilly, P Levine, J Rothbard, et al.
Molecular Immunology|September 1, 1988
The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulinsN Kishore, D Shah, V M Skanes, et al.
Complement (Basel, Switzerland)|January 1, 1988
C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1L Paul, V M Skanes, J Mayden, et al.
Autoimmunity|January 1, 1988
Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye diseaseM Frecker, G Mercer, V M Skanes, et al.
Arthritis and Rheumatism|September 1, 1987
Deletion of C4A genes in patients with systemic lupus erythematosusM E Kemp, J P Atkinson, V M Skanes, et al.
Molecular Biology & Medicine|April 1, 1986
Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditisV M Skanes, J Barnard, N Farid, et al.
Pageof 2